GSK's Covid-related sales hit £1.4 billion
GSK racked up £1.4 billion in Covid-related sales in 2021, largely for antibody drug sotrovimab, as it beat quarterly forecasts in its first earnings report since rejecting a bid from Unilever for its consumer arm.
Business
• 09 Feb 22
